BCG vaccine immunity against human tuberculosis. The BCG vaccine can be anywhere from 0 to 80% effective in preventing tuberculosis for a duration of 15 years; however, its protective effect appears to vary according to geography and the lab in which the vaccine strain was grown. A number of different companies make BCG, sometimes using different genetic strains of the bacterium. This may result in different product characteristics. OncoTICE, used for bladder instillation for bladder cancer, was developed by Organon Laboratories (since acquired by Schering-Plough, and in turn acquired by Merck & Co.). Pacis BCG, made from the Montréal (Institut Armand-Frappier) strain,
Inoculation theory an individual. Future studies in the area of health can be extremely beneficial to communities. Some areas that are currently being researched can possibly help with present-day issues (e.g., inoculation-based strategies for addiction intervention to assist sober individuals from relapsing). Other areas for future studies include, promoting healthy eating habits, exercising, breastfeeding and creating positive attitude towards mammograms (Ivanov, 2017). An area that has been underdeveloped is mental health awareness. With the number of young adults and teens committing suicide due to bullying this can be an area where inoculation messages could be effective. McGuire (1961) used a medical analogy